The rVSV-EBOV vaccine provides limited cross-protection against Sudan virus in guinea pigs

Abstract Recombinant vesicular stomatitis viruses (rVSVs) engineered to express heterologous viral glycoproteins have proven to be remarkably effective vaccines. Indeed, rVSV-EBOV, which expresses the Ebola virus (EBOV) glycoprotein, recently received clinical approval in the United States and Europ...

Full description

Bibliographic Details

Published in:	npj Vaccines
Main Authors:	Wenguang Cao, Shihua He, Guodong Liu, Helene Schulz, Karla Emeterio, Michael Chan, Kevin Tierney, Kim Azaransky, Geoff Soule, Nikesh Tailor, Abdjeleel Salawudeen, Rick Nichols, Joan Fusco, David Safronetz, Logan Banadyga
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-06-01
Online Access:	https://doi.org/10.1038/s41541-023-00685-z